| Benefits and harms of sodium-glucose co-transporter 2 inhibitors in patients with type 2 diabetes: a systematic review and meta-analysis H Storgaard, LL Gluud, C Bennett, MF Grøndahl, MB Christensen, ... PloS one 11 (11), e0166125, 2016 | 277 | 2016 |
| Evidence of extrapancreatic glucagon secretion in man A Lund, JI Bagger, NJ Wewer Albrechtsen, M Christensen, M Grøndahl, ... Diabetes 65 (3), 585-597, 2016 | 172 | 2016 |
| Effects of smoking versus nonsmoking on postprandial glucose metabolism in heavy smokers compared with nonsmokers MF Grøndahl, JI Bagger, A Lund, A Faurschou, JF Rehfeld, JJ Holst, ... Diabetes Care 41 (6), 1260-1267, 2018 | 22 | 2018 |
| Current therapies that modify glucagon secretion: what is the therapeutic effect of such modifications? MF Grøndahl, DJ Keating, T Vilsbøll, FK Knop Current diabetes reports 17, 1-10, 2017 | 22 | 2017 |
| Higher endogenous glucose production during OGTT vs isoglycemic intravenous glucose infusion A Lund, JI Bagger, M Christensen, M Grøndahl, G van Hall, JJ Holst, ... The Journal of Clinical Endocrinology & Metabolism 101 (11), 4377-4384, 2016 | 20 | 2016 |
| Glucagonostatic potency of GLP-1 in patients with type 2 diabetes, patients with type 1 diabetes, and healthy control subjects JI Bagger, MFG Grøndahl, A Lund, JJ Holst, T Vilsbøll, FK Knop Diabetes 70 (6), 1347-1356, 2021 | 11 | 2021 |
| Glucagon clearance is preserved in type 2 diabetes MFG Grøndahl, AB Lund, JI Bagger, TS Petersen, NJ Wewer Albrechtsen, ... Diabetes 71 (1), 73-82, 2022 | 9 | 2022 |
| Treatment of type 2 diabetes in children: what are the specific considerations? MFG Grøndahl, J Johannesen, K Kristensen, FK Knop Expert Opinion on Pharmacotherapy 22 (16), 2127-2141, 2021 | 9 | 2021 |
| Is glucagon‐like peptide‐1 fully protected by the dipeptidyl peptidase 4 inhibitor sitagliptin when administered to patients with type 2 diabetes? ES Andersen, A Lund, JI Bagger, C Andreasen, MF Grøndahl, CF Deacon, ... Diabetes, Obesity and Metabolism 20 (8), 1937-1943, 2018 | 4 | 2018 |
| Metabolic effects of 1-week binge drinking and fast food intake during Roskilde Festival in young healthy male adults M Demant, MP Suppli, S Foghsgaard, L Gether, MFG Grøndahl, ... European Journal of Endocrinology 185 (1), 23-32, 2021 | 3 | 2021 |
| Gastrointestinal-mediated glucose disposal in total pancreatectomised patients A Lund, JI Bagger, M Christensen, M Grondahl, ER Mathiesen, ... Diabetologia 57, S224-S224, 2014 | 1 | 2014 |
| The effect of exogenous glucagon on circulating amino acids in individuals with and without type 2 diabetes and obesity MFG Grøndahl, JI Bagger, MP Suppli, G Van Hall, NJW Albrechtsen, ... Endocrine Connections 13 (3), 2024 | | 2024 |
| 1651-P: Elevated FGF21 Levels after Total Pancreatectomy and in Response to Single-Dose Glucagon Receptor Antagonism in Humans MFG GRØNDAHL, CT JUEL, A LUND, S HAEDERSDAL, ... Diabetes 72 (Supplement_1), 2023 | | 2023 |
| Increased liver fat content in totally pancreatectomised patients JI Bagger, A Lund, NJW Albrechtsen, M Christensen, M Grøndahl, ... 53rd Annual Meeting of the European Association for the study of Diabetes EASD, 2017 | | 2017 |
| Erratum. Evidence of Extrapancreatic Glucagon Secretion in Man. Diabetes 2016; 65: 585–597 M Christensen, M Grøndahl, B Hartmann, ER Mathiesen, CP Hansen, ... Diabetes 65, 585-597, 2016 | | 2016 |
Filip K KnopDirector, Center for Diabetes Research, Gentofte Hospital, University of Copenhagen, DenmarkVerified email at dadlnet.dk
